The influence of tethered epidermal growth factor on connective tissue progenitor colony formation

Biomaterials

Volumn 30, Issue 27, 2009, Pages 4629-4638

  Marcantonio, Nicholas A ^a   Boehm, Cynthia A ^b   Rozic, Richard J ^b   Au, Ada ^a   Wells, Alan ^c   Muschler, George F ^b   Griffith, Linda G ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecule; Bone tissue engineering; Connective tissue; Growth factors; Mesenchymal stem cell; Stem cell

Indexed keywords

ADHESION MOLECULE; BONE TISSUE ENGINEERING; CONNECTIVE TISSUE; GROWTH FACTORS; MESENCHYMAL STEM CELL; STEM CELL;

ADHESION; AVIATION; BIOACTIVITY; BONE; CELL CULTURE; CELL MEMBRANES; COLLAGEN; GROWTH KINETICS; PEPTIDES; SCAFFOLDS; SIGNALING;

TISSUE ENGINEERING;

EPIDERMAL GROWTH FACTOR;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; COLONY FORMATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CULTURE MEDIUM; DONOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

ADSORPTION; CELL ADHESION; CELL COUNT; CELL DIFFERENTIATION; CELL SIZE; COLONY-FORMING UNITS ASSAY; CONNECTIVE TISSUE CELLS; EPIDERMAL GROWTH FACTOR; FIBRONECTINS; HUMANS; OSTEOGENESIS; PEPTIDES; POLYMERS; SERUM; SOLUBILITY; STEM CELLS;

EID: 67651151049     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.05.061     Document Type: Article

References (56)

1. Owen M., and Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136 (1988) 42-60
2. Majors A.K., Boehm C.A., Nitto H., Midura R.J., and Muschler G.F. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15 4 (1997) 546-557
3. Muschler G.F., Nitto H., Boehm C.A., and Easley K.A. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19 1 (2001) 117-125
4. Friedenstein A.J. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol Blood Transfus 25 (1980) 19-29
5. Caplan A.I. Mesenchymal stem cells. J Orthop Res 9 5 (1991) 641-650
6. Bianco P., Kuznetov S.A., Riminucci M., and Robey P.G. Postnatal skeletal stem cells. Meth Enzymol 419 (2006) 117-148
7. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
8. Reyes M., and Verfaillie C.M. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 938 (2001) 231-233
9. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7 5 (2005) 393-395
10. Patterson T.E., Kumagai K., Griffith L., and Muschler G.F. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 90 Suppl. 1 (2008) 111-119
11. Muschler G.F., Nakamoto C., and Griffith L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A 7 (2004) 1541-1558
12. Healey J.H., Zimmerman P.A., McDonnell J.M., and Lane J.M. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 256 (1990) 280-285
13. Connolly J.F., Guse R., Tiedeman J., and Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 266 (1991) 259-270
14. Garg N.K., and Gaur S. Percutaneous autogenous bone-marrow grafting in congenital tibial pseudarthrosis. J Bone Joint Surg Br 77 5 (1995) 830-831
15. Muschler G.F., Matsukura Y., Nitto H., Boehm C.A., Valdevit A.D., Kambic H.E., et al. Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res 432 (2005) 242-251
16. Muschler G.F., Nitto H., Matsukura Y., Boehm C., Valdevit A., Kambic H., et al. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res 407 (2003) 102-118
17. Brodke D., Pedrozo H.A., Kapur T.A., Attawia M., Kraus K.H., Holy C.E., et al. Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft. J Orthop Res 24 5 (2006) 857-866
18. Wang K., Yamamoto H., Chin J.R., Werb Z., and Vu T.H. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem 279 51 (2004) 53848-53856
19. Sibilia M., Wagner B., Hoebertz A., Elliott C., Marino S., Jochum W., et al. Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130 19 (2003) 4515-4525
20. Qin L., Tamasi J., Raggatt L., Li X., Feyen J.H., Lee D.C., et al. Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280 5 (2005) 3974-3981
21. Chan S.Y., and Wong R.W. Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275 49 (2000) 38693-38698
22. Kratchmarova I., Blagoev B., Haack-Sorensen M., Kassem M., and Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308 5727 (2005) 1472-1477
23. Kuznetsov S.A., Friedenstein A.J., and Robey P.G. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 97 3 (1997) 561-570
24. Kimura A., Katoh O., and Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-beta on the growth of human marrow fibroblasts. Br J Haematol 69 1 (1988) 9-12
25. Gronthos S., and Simmons P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85 4 (1995 Feb 15) 929-940
26. Owen M.E., Cave J., and Joyner C.J. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 87 Pt 5 (1987) 731-738
27. Satomura K., Derubeis A.R., Fedarko N.S., Ibaraki-O'Connor K., Kuznetsov S.A., Rowe D.W., et al. Receptor tyrosine kinase expression in human bone marrow stromal cells. J Cell Physiol 177 3 (1998) 426-438
28. Tamama K., Fan V.H., Griffith L.G., Blair H.C., and Wells A. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 24 3 (2006) 686-695
29. Kuhl P.R., and Griffith-Cima L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med 2 9 (1996) 1022-1027
30. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., et al. Tethered EGF provides a survival advantage to mesenchymal stem cells. Stem Cells 25 5 (2007) 1241-1251
31. Kuhlman W., Taniguchi I., Griffith L.G., and Mayes A.M. Interplay between PEO tether length and ligand spacing governs cell spreading on RGD-modified PMMA-g-PEO comb copolymers. Biomacromolecules 8 10 (2007) 3206-3213
32. Irvine D.J., Mayes A.M., and Griffith L.G. Nanoscale clustering of RGD peptides at surfaces using Comb polymers. 1. Synthesis and characterization of Comb thin films. Biomacromolecules 2 1 (2001) 85-94
33. Au A., Boehm C.A., Mayes A.M., Muschler G.F., and Griffith L.G. Formation of osteogenic colonies on well-defined adhesion peptides by freshly isolated human marrow cells. Biomaterials 28 10 (2007) 1847-1861
34. Kuhlman W., Olivetti E., Mayes A.M., and Griffith L.G. Chain conformations at the surface of a polydisperse comb co-polymer film. Macromolecules 8 10 (2006) 3206-3213
35. Powell K.A., Nakamoto C., Villarruel S., Boehm C., and Muschler G. Quantitative image analysis of connective tissue progenitors. Anal Quant Cytol Histol 29 2 (2007) 112-121
36. Docheva D., Popov C., Mutschler W., and Schieker M. Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med 11 1 (2007) 21-38
37. Gronthos S., Simmons P.J., Graves S.E., and Robey P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 26 2 (2001) 174-181
38. Garcia A.J., Schwarzbauer J.E., and Boettiger D. Distinct activation states of alpha 5 beta 1 integrin show differential binding to RGD and synergy domains of fibronectin. Biochemistry 41 29 (2002) 9063-9069
39. Hautanen A., Gailit J., Mann D.M., and Ruoslahti E. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 264 3 (1989) 1437-1442
40. Petrie T.A., Capadona J.R., Reyes C.D., and Garcia A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 27 31 (2006) 5459-5470
41. Morgan M.R., Humphries M.J., and Bass M.D. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8 12 (2007) 957-969
42. Kempiak S.J., Yip S.C., Backer J.M., and Segall J.E. Local signaling by the EGF receptor. J Cell Biol 162 5 (2003) 781-787
43. Banno A., and Ginsberg M.H. Integrin activation. Biochem Soc Trans 36 Pt 2 (2008) 229-234
44. Manton K.J., Leong D.F., Cool S.M., and Nurcombe V. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cells 25 11 (2007) 2845-2854
45. Krampera M., Pasini A., Rigo A., Scupoli M.T., Tecchio C., Malpeli G., et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106 1 (2005) 59-66
46. Wiley H.S. Trafficking of the ErbB receptors and its influence on signaling. Exp Cell Res 284 1 (2003) 78-88
47. Iyer A.K., Tran K.T., Griffith L., and Wells A. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol 214 2 (2008) 504-512
48. ras in fibroblasts. J Biol Chem 274 (1999) 34350-34360
49. Wells A., Ware M.F., Allen F.D., and Lauffenburger D.A. Shaping up for shipping out: PLCγ signaling of morphology changes in EGF-stimulated fibroblast migration. Cell Motil Cytoskeleton 44 4 (1999) 227-233
50. Haugh J.M., Schooler K., Wells A., Wiley H.S., and Lauffenburger D.A. Effect of epidermal growth factor receptor internalization on regulation of the phospholipase C-γ signaling pathway. J Biol Chem 274 (1999) 8958-8965
51. Swindle C.S., Tran K.T., Johnson T.D., Banerjee P., Mayes A.M., Griffith L., et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J Cell Biol 154 2 (2001) 459-468
52. Maheshwari G., Wells A., Griffith L.G., and Lauffenburger D.A. Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. Biophys J 76 5 (1999) 2814-2823
53. Sibilia M., Fleischmann A., Behrens A., Stingl L., Carroll J., Watt F.M., et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102 2 (2000) 211-220
54. Yarram S.J., Tasman C., Gidley J., Clare M., Sandy J.R., and Mansell J.P. Epidermal growth factor and calcitriol synergistically induce osteoblast maturation. Mol Cell Endocrinol 220 1-2 (2004) 9-20
55. Schreiber A.B., Winkler M.E., and Derynck R. Transforming growth factor-alpha - a more potent angiogenic mediator than epidermal growth factor. Science 232 4755 (1986) 1250-1253
56. Zhu J., Jia X., Xiao G., Kang Y., Partridge N.C., and Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts - implications for osteolytic bone metastases. J Biol Chem 282 37 (2007) 26656-26665